Antiphospholipid syndrome with isolated CNS manifestations and multiple sclerosis-like syndrome
Keywords:
antiphospholipid syndrome, differential diagnosis, multiple sclerosisAbstract
The antiphospholipid syndrome is a systemic autoimmune disorder characterized by the presence of circulating procoagulant autoantibodies and the occurrence of recurrent arterial or venous thrombosis. Central nervous system manifestations are common and include stroke, transient ischemic attacks, cognitive dysfunction, migraine, seizures, movement disorders, psychiatry symptoms, multiple sclerosis-like syndrome, transverse myelitis and retrobulbar neuritis. Isolated neurological antiphospholipid syndrome may represent a significant diagnostic challenge, as epidemiological, clinical and neuroimaging features may overlap with those of multiple sclerosis. Differential diagnosis between multiple sclerosis and antiphospholipid syndrome is very difficult but it is extremely important because prompt and correct treatment can improve quality of life and may also reduce mortality in the affected patients.
We present a clinical case of antiphospholipid syndrome, misdiagnosed as multiple sclerosis in 29-year-old patient, who was sent to UMHATNP “St. Naum” for initiating disease modifying therapy. The diagnosis was revised and the patient was consulted with reumatolagist and hematologist, an oral anticoagulant therapy was started.
References
Milanov, I. Mnozhestvena skleroza i avtoimunni demielinizirashti zabolyavaniya na tsentralnata nervna sistema. Meditsina i fizkultura, Sofiya, 2014.]
D'Angelo, C., Franch, O., Fernandez-Paredes, L., Oreja- Guevara, C., Núñez-Beltrán, M., Comins-Boo, A., Reale, M., Sánchez-Ramón, S. Antiphospholipid antibodies overlapping in isolated neurological syndrome and multiple sclerosis: neurobiological in-sights and diagnostic challenges. Frontiers in Cellular Neuroscience, 2019, 13, 107, 1-13.
Garcia, D., Erkan, D. Diagnosis and management of the antiphospholipid syndrome. The New England Journal of Medicine, 2018, 378, 2010-2021.
Graf, J. Central nervous system manifestations of antiphospholipid syndrome. Rheumatic Disease Clinics of North America, 2017, 43, 547-560.
Mayer, M., Cerovec, M., Rados, M., Cikes, N. Antiphospholipid syndrome and central nervous system. Clinical Neurology and Neurosurgery, 2010, 112, 602-608.
Ricarte, I.F., Dutra, L.A., Abrantes, F.F., Toso, F.F., Barsottini, O.G.P., Silva, G.S., de Souza, A.W.S., Andrade, D. Neurologic manifestations of antiphospholipid syndrome. Lupus, 2018, 27, 1404-1414.
Thompson, A.J., Banwell, B.L., Barkhof, F., Carroll, W.M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Fredman, M.S., Fujihara, K., Galetta, S.L., Hartung, H.P., Kappos, L., Lublin, F.D., Marrie, R.A., Miller, A.E., Miller, D.H., Montalban, X., Mowry, E.M., Sorensen, P.S., Tintoré, M., Traboulsee, A.L., Trojano, M., Uitdehaag, B.M., Vukusic, S., Waubant, E., Weinshenker, B.G., Reingold, S.C., Cohen, J.A. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology, 2018, 17, 162-173.
Sammaritano, L.R. Antiphospholipid syndrome. Best Practice and Research Clinical Rheumatology, 2020, 34, 1-16.
Uthman, I., Noureldine, M.H.A., Berjawi, A., Skaf, M., Haydar, A.A., Merashli, M., Hughes, G.R.V. Hughes syndrome and multiple sclerosis. Lupus, 2015, 24, 115-121.
Wildner, P., Stasiołek, M., Matysiak, M. Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases. Multiple Sclerosis and Related Disorders, 2020, 37, 1-11.
Yelnik, C.M., Kozora, E., Appenzeller, S. Non-stroke central neurologic manifestations in antiphospholipid syndrome. Current Rheumatology Reports, 2016, 18, 11, 1-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Antonia Nikolova, I. Milanov, S. Ivanova, N. Topalov, S. Shopova

This work is licensed under a Creative Commons Attribution 4.0 International License.